A different method of evaluation of the ERSPC trial confirms that PSA testing has a significant impact on prostate cancer mortality

The advantages and disadvantages of two different methods of analyzing the European Randomized Study of Screening for Prostate Cancer (ERSPC) trial with respect to the effect of prostate-specific antigen (PSA) screening on prostate cancer (PC) mortality (i.e., disease-specific mortality analysis and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Urol
Main Authors: Zappa, Marco, Puliti, Donella, Hugosson, Jonas, Schröder, Fritz H., van Leeuwen, Pim J., Kranse, Ries, Auvinen, Anssi, Carlsson, Sigrid, Kwiatkowski, Maciej, Nelen, Vera, Borda, Alvaro Paez, Roobol, Monique J., Villers, Arnauld
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5615402/
https://ncbi.nlm.nih.gov/pubmed/24412230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2013.12.055
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados